Live Breaking News & Updates on Ascendis Pharma Group|Page 1

Stay updated with breaking news from Ascendis pharma group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024

COPENHAGEN, Denmark, April 25, 2024 Ascendis Pharma A/S today announced it will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024, after the. ....

United States , Melinda Baker , Ascendis Pharma , Tim Lee , Ascendis Pharma Group , Exchange Commission , Globenewswire Inc , Patti Bank , Ascendi Annual Report ,

Ascendis Pharma's Initial Dose Escalation Results from the Ongoing Phase 1/2 Trial of TransCon IL-2 ß/? Accepted for Online Publication at ASCO 2023

COPENHAGEN, Denmark, April 03, 2023 (GLOBE NEWSWIRE) Ascendis Pharma A/S (Nasdaq: ASND) today announced that initial dose escalation data from the Company's ongoing Phase 1/2 IL-Believe Trial of TransCon ....

Palo Alto , United States , Baden Wüberg , Redwood City , New Jersey , Ascendis Pharma , Tim Lee , Stina Singel , Melinda Baker , Patti Bank , Head Of Clinical Development , American Society Of Clinical Oncology , Exchange Commission , Ascendis Pharma Group , Believe Trial , American Society , Clinical Oncology , Executive Vice President , Clinical Development , Ascendi Annual Report ,

Ascendis Pharma's Initial Dose Escalation Results from the Ongoing Phase 1/2 Trial of TransCon™ IL-2 β/γ Accepted for Online Publication at ASCO 2023

COPENHAGEN, Denmark, April 03, 2023 Ascendis Pharma A/S today announced that initial dose escalation data from the Company’s ongoing Phase 1/2 IL-Believe Trial of TransCon IL-2. | April 3, 2023 ....

United States , New Jersey , Redwood City , Baden Wüberg , Palo Alto , Ascendis Pharma , Stina Singel , Melinda Baker , Tim Lee , Exchange Commission , Globenewswire Inc , American Society Of Clinical Oncology , Ascendis Pharma Group , Patti Bank , Head Of Clinical Development , Believe Trial , Clinical Oncology , Executive Vice President , Clinical Development , Ascendi Annual Report , Ascendis Pharmaas Stock Exchange , Press Release , Ranscon Asnd Us04351p1012 ,

Ascendis Pharma Provides Update on Vision 3x3 Strategic Roadmap at 41st Annual J.P. Morgan Healthcare Conference

– On track to fulfill all elements of Vision 3x3 to build a sustainable, profitable, leading biopharma company COPENHAGEN, Denmark, Jan. 08, 2023 Ascendis Pharma A/S today. | January 8, 2023 ....

United States , New Jersey , Palo Alto , Redwood City , Baden Wüberg , Ascendis Pharma , Jan Mikkelsen , Melinda Baker , Tim Lee , Us Expanded Access Program , Exchange Commission , International Financial Reporting Standards , Ascendis Pharma Group , European Commission , Patti Bank , Globenewswire Inc , Chief Executive , North American , Access Program , Transcon Hydrogel Platform , Healthcare Conference , Investor Relations , Ascendi Annual Report , International Financial Reporting , Ascendis Pharmaas Stock Exchange , Press Release ,

Ascendis Pharma (ASND) Reports Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101

Ascendis Pharma (ASND) Reports Recommended Phase 2 Dose and Cohort Expansion for transcendIT-101
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New Jersey , United States , Palo Alto , Redwood City , Baden Wüberg , Ascendis Pharma , Ascendi Transcon , Ascendis Pharma Transcon , Stina Singel , Exchange Commission , Head Of Clinical Development , Society For Immunotherapy Of Cancer , Ascendis Pharma Group , Wall Street , Senior Vice President , Clinical Development , Looking Statementsthis , Ascendi Annual Report ,